A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer

NCT05068024 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: FWD1509 MsOH

Sponsor

Forward Pharmaceuticals Co., Ltd.

Collaborators

[object Object]